| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/11/2011 | CN101222909B Breath freshening and oral cleansing product with magnolia bark extract in combination with surface active agents |
| 05/11/2011 | CN101217962B Therapeutic agents targeting the NCCa-ATP channel and methods of use thereof |
| 05/11/2011 | CN101195799B SOD distillate spirits and manufacturing method thereof |
| 05/11/2011 | CN101190914B 16-site substituted double functional group huperzine B derivative, preparation method and use thereof |
| 05/11/2011 | CN101190228B Compound triamcinolone acetonide acetate solution production technology |
| 05/11/2011 | CN101186583B Methyl 2-(2-(2,6-dichlorophenylamino)phenyl)acetate and its synthesizing method and application |
| 05/11/2011 | CN101167736B Azithromycin microball preparation and preparation method thereof |
| 05/11/2011 | CN101157717B Preparation method of Ardisia mamillata B and uses thereof |
| 05/11/2011 | CN101155794B Crystalline form of 1-chloro-4-(ss-d-glucopyranos-1-yl)-2-[4-((s)-tetrahydrofuran-3-yloxy)-benzyl]-benzene, a method for its preparation and the use thereof for preparing medicaments |
| 05/11/2011 | CN101152162B Transdermal drug delivery preparation containing arteannuin or its derivant and use of the same |
| 05/11/2011 | CN101129565B Medicament for treating beriberi, sweaty feet and foot odor |
| 05/11/2011 | CN101121743B Process for extracting anticancer product from natural plant |
| 05/11/2011 | CN101121677B Agmatine sulfate dihydrate and medical use thereof |
| 05/11/2011 | CN101117385B New polysiloxanes with quaternary ammonium groups, method for their manufacture and their use in cleaning and treating formulations |
| 05/11/2011 | CN101112421B Slimming capsule preparations |
| 05/11/2011 | CN101104864B Method for preparing epothilones B |
| 05/11/2011 | CN101103032B Bicyclic pyrrole derivatives |
| 05/11/2011 | CN101100469B Novel crystal of doripenem, preparation method and use thereof |
| 05/11/2011 | CN101096363B 2,4,5-three-substituted thiazole compound, preparation method, medicament composition and pharmacy use thereof |
| 05/11/2011 | CN101085283B Vein relaxing externally used lotion for dermatosis |
| 05/11/2011 | CN101081315B Method for forming medical devices containing rapamycin analogs |
| 05/11/2011 | CN101080405B Quaternary ammonium salts as M3 antagonists |
| 05/11/2011 | CN101072561B Diaminoalkane aspartic protease inhibitors |
| 05/11/2011 | CN101054352B New strontium salts of sulphonic acids, a process for their preparation and pharmaceutical compositions containing them |
| 05/11/2011 | CN101052640B Pyridine methylene azolidinones and use thereof phosphoinositide inhibitors |
| 05/11/2011 | CN101050179B 2,3,4,5-tetrasubstituted derivatives of benzyl ethylene class, preparation method and application |
| 05/11/2011 | CN101032486B Medical plants synergist having antifungal activity and drug tolerance of reversion azole antifungal agents |
| 05/11/2011 | CN101027302B Pyrrolo-pyridine kinase modulators |
| 05/11/2011 | CN101022793B Dietary compositions for enhancing metabolism and reducing reactive oxygen species |
| 05/11/2011 | CN101007804B 1,3-benzodioxole-2,2-dicarboxylic acid derivatives and their preparation method and medicinal uses |
| 05/10/2011 | USRE42353 Quinazoline derivatives and pharmaceutical compositions containing them |
| 05/10/2011 | US7941211 Potentiation with zeaxanthin; imparting yellowish color prior to administering light activated drugs; wet (exudative) macular degeneration |
| 05/10/2011 | US7939689 Short-acting sedative hypnotic agents for anesthesia and sedation |
| 05/10/2011 | US7939686 Immersing in aqueous bath, separation, drying; quaternized cationic copolymer of octadecylaminodimethyltrihydroxysilylpropyl ammonium chloride and chloropropyltrihydroxysilane |
| 05/10/2011 | US7939677 Oligomeric compounds comprising 4′-thionucleosides for use in gene modulation |
| 05/10/2011 | US7939671 Compounds that inhibit (block) bitter taste in composition and use thereof |
| 05/10/2011 | US7939670 Nociceptin analogs |
| 05/10/2011 | US7939667 Hepatitis C inhibitor compounds |
| 05/10/2011 | US7939662 Amorphous ziprasidone hydrochloride (5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2H-indol-2-one hydrochloride) and processes to produce the same |
| 05/10/2011 | US7939661 Pyridine, quinoline and pyrimidine derivatives |
| 05/10/2011 | US7939660 Process and intermediates for preparing emtricitabine |
| 05/10/2011 | US7939658 Enantiomeric pure beta agonists, manufacturing and use as a medicaments thereof |
| 05/10/2011 | US7939657 N-substituted benzene sulfonamides |
| 05/10/2011 | US7939655 Process for preparing a sterile high molecular weight hyaluronic acid formulation |
| 05/10/2011 | US7939654 Platelet derived growth factor (PDGF) nucleic acid ligand complexes |
| 05/10/2011 | US7939653 Sensizitation of cancer cells to therapy using siNA targeting genes from the 1p and 19q chromosomal regions |
| 05/10/2011 | US7939652 Oligoribonucleotides and methods of use thereof for treatment of fibrotic conditions and other diseases |
| 05/10/2011 | US7939650 For stimulating release of tumor necrosis factor and/or cellular prolifefration/differentiation of chondrocytes by contacting blood w/polypeptide; diagnosis cancer |
| 05/10/2011 | US7939639 Functional role of adrenomedullin (AM) and the gene related product (PAMP) in human pathology and physiology |
| 05/10/2011 | US7939568 Use of a composition comprising vitamin K1 oxide or a derivative thereof for the treatment and/or the prevention of mammal dermatological lesions |
| 05/10/2011 | US7939566 Crystalline form III of agomelatine, a process for its preparation and pharmaceutical compositions containing it |
| 05/10/2011 | US7939564 hyperthermia treatment or radiotherapy; synergistic with Taxol and taxane analogs; heat shock proteins and natural killer cells and reactive oxygen species controller |
| 05/10/2011 | US7939563 Remedy for hypertension |
| 05/10/2011 | US7939562 fatty acid chain are derived from natural vegetable oils such as vernonia oil, lesquerella oil and castor oil, in which the several reactive groups such as epoxy, hydroxy and double bonds can be modified to polar and ionic groups |
| 05/10/2011 | US7939561 Blister packaging for acute pain regimens |
| 05/10/2011 | US7939560 Fluorescent particles comprising nanoscale ZnO layer and exhibiting cell-specific toxicity |
| 05/10/2011 | US7939559 Lipase inhibitors |
| 05/10/2011 | US7939558 Compounds having activity in increasing ion transport by mutant-CFTR and uses thereof |
| 05/10/2011 | US7939557 Vascular endothelial receptor specific inhibitors |
| 05/10/2011 | US7939556 Imidazole derivatives and their use for modulating the GABAA receptor complex |
| 05/10/2011 | US7939555 Method of preparing a pharmaceutical cream and minimizing imiquimod impurity formation |
| 05/10/2011 | US7939554 Protein phosphatase inhibitors |
| 05/10/2011 | US7939553 Modulators of pharmacokinetic properties of therapeutics |
| 05/10/2011 | US7939552 Benzyloxypropylamine derivative |
| 05/10/2011 | US7939551 for diabetes mellitus and other metabolic disorders; compounds of given formula such as sulfonamides and an antidiabetic agent such as sulfonylureas, biguanides, glitazones, alpha-glucosidase inhibitors, glucagon antagonists |
| 05/10/2011 | US7939550 Aminopyrazole derivatives, process for the preparation thereof, and composition for preventing or treating ischemic diseases containing the same |
| 05/10/2011 | US7939549 1,2-dihydropyridine compounds, manufacturing method thereof and use thereof |
| 05/10/2011 | US7939548 Certain chemical entities, compositions, and methods |
| 05/10/2011 | US7939547 Compounds and compositions as channel activating protease inhibitors |
| 05/10/2011 | US7939546 Quinoline derivatives for modulating DNA methylation |
| 05/10/2011 | US7939545 Inhibitors of human immunodeficiency virus replication |
| 05/10/2011 | US7939544 Octahydropentalene compounds as chemokine receptor antagonists |
| 05/10/2011 | US7939543 Method of reducing α, β unsaturated ketones in opioid compositions |
| 05/10/2011 | US7939542 Cinnamaldehyde derivatives having improved solubility in water, a method for preparing the same and a pharmaceutical composition comprising the same |
| 05/10/2011 | US7939541 Condensing (3-trifluoromethylsulfonyl) benzoyl chloride and 4-methyl-2-nitro-aniline; reducing nitro group with stannous chloride; condensing amino group with cyanamide; cyclocondensing guanidine group with 3-dimethylamino-1-pyridin-3-yl-propenone; antiproliferative agent |
| 05/10/2011 | US7939540 4-(3-benzoylaminophenyl)-6,7-dimethoxy-2-methylaminoquinazoline derivatives |
| 05/10/2011 | US7939539 Quinazolinone compounds as anticancer agents |
| 05/10/2011 | US7939538 Compounds, compositions and methods for prevention and treatment of inflammatory and immunoregulatory disorders and diseases |
| 05/10/2011 | US7939537 HIV integrase inhibitors |
| 05/10/2011 | US7939536 Pyrimidinylisoxazole derivatives |
| 05/10/2011 | US7939535 Benzo[D]isoxazol-3-yl-piperazin derivatives useful as modulators of dopamine D3 receptors |
| 05/10/2011 | US7939534 Certain chemical entities, compositions, and methods |
| 05/10/2011 | US7939533 Dual NK1/NK3 receptor antagonists |
| 05/10/2011 | US7939532 Heterocyclyl pyridyl sulfonamide derivatives, their manufacture and use as pharmaceutical agents |
| 05/10/2011 | US7939531 Pyrrolopyrazine kinase inhibitors |
| 05/10/2011 | US7939530 Treatment of lymphoma using 10-propargyl-10-deazaaminopterin and gemcitabine |
| 05/10/2011 | US7939529 Substantially pure 2-(5-(4-(2-morpholinoethoxy)phenyl)pyridin-2-yl)-N-benzylacetamide salts, solvates, hydrates, prodrugs; hyperproliferative disorders, cancers, pre-cancers, osteoporosis, cardiovascular disorders; bacterial, fungal, parasitic or viral infection |
| 05/10/2011 | US7939528 Heterocycle compounds |
| 05/10/2011 | US7939527 Thiazolopyridin-2-yloxy-phenyl and thiazolopyrazin-2-yloxy-phenyl amines as modulators of leukotriene A4 hydrolase |
| 05/10/2011 | US7939526 Sulfone substituted imidazo ring ethers |
| 05/10/2011 | US7939525 Conjugated psychotropic drugs and uses thereof |
| 05/10/2011 | US7939524 5,6-dihydro-1H-pyridin-2-one compounds |
| 05/10/2011 | US7939523 Imidazolidinone and imidazolidinethione derivatives |
| 05/10/2011 | US7939522 Dosage formulations for acetylcholinesterase inhibitors |
| 05/10/2011 | US7939521 2-arylpropionic acid derivatives and pharmaceutical compositions containing them |
| 05/10/2011 | US7939520 Aminoazacyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands |
| 05/10/2011 | US7939519 Immunosuppresant compounds and compositions |
| 05/10/2011 | US7939518 Method of treating post-surgical acute pain |
| 05/10/2011 | US7939517 1,4,6-androstatriene-3,17-dione (“ATD”) for therapeutic uses |
| 05/10/2011 | US7939516 Topical skin care composition |